Kiwon lafiyaShirye-shirye

Yana nufin 'Flemoklav-soljutab'. Umarnin don amfani

Yana nufin "Flemoklav-soljutab" Umarni a kan aikace-aikace ya bayyana a matsayin wani kwayoyin wakili tare da mai fadi da kewayon effects. A shirye-shiryen hada clavulanic acid da kuma amoxicillin. A medicament yana da wani bactericidal sakamako. A miyagun ƙwayoyi aiki da yawa kwayoyin - gram-korau da gram-tabbatacce, aerobic da anaerobic. Bayar da miyagun ƙwayoyi "Flemoklav-soljutab" wa'azi ga yara da kuma manya dauki a hade tare da wani antihistamine.

Matsakaicin abun ciki na amoxicillin lura bayan daya ko biyu sa'o'i bayan karbar medicament. A bangaren da yake iya shiga cikin nono madara da kuma placental shamaki (a kananan yawa).

Matsakaicin abun ciki na clavulanic acid da aka lura bayan game da sa'o'i biyu bayan gwamnati. Ba a shigar da damar bangaren wuce a cikin nono. Clavulanic acid da aka ratsa placental shãmaki.

A mataki na sha na aiki sinadaran da miyagun ƙwayoyi "Flemoklav-soljutab" (umurci manual hada da irin data) abincin ci yana da wani tasiri.

Da miyagun ƙwayoyi nuna ga cututtuka da kuma kumburi yanayi, ya sa ta hanyar pathogens exhibiting ƙwarai a cikinta (miyagun ƙwayoyi). Da miyagun ƙwayoyi "Flemoklav-soljutab" umurci manual bada shawarar cewa marasa lafiya da raunuka a taushi tsokoki na manya da ƙananan numfashi fili (pharyngitis, sinusitis, otitis kafofin watsa labarai (na tsakiya), tonsillitis). An wajabta magani ga fata cututtuka, urinary fili gabobin.

A lokacin binciken, da teratogenic sakamakon da miyagun ƙwayoyi a kan yanayin da ciki mace, tayin ko da jariri ba a saukar. Na nufin "Flemoklav-soljutab" umurci manual ya wadãtu da lafiya magani da kuma damar da saduwa a lokacin gestation (a trimester 2 da kuma 3). Alƙawari a farko trimester ciki ne da za'ayi tare da taka tsantsan.

Duk da cewa amoxicillin wuce a cikin ƙirjinka madara, da mummunan tasiri a kan Jihar jariri nono yayin da shan magani "Flemoklav-soljutab" aka lura.

Da miyagun ƙwayoyi ne contraindicated a hanta tabarbarewa ko jaundice lokacin da ake ji clavulanate ko amoxycillin, hypersensitivity da miyagun ƙwayoyi aka gyara, kazalika da sauran beta-lactam kwayoyin kwayoyi (cephalosporins, penicillins). Ba don rubũta magani idan lymphocytic cutar sankarar bargo, dauke da kwayar cutar mononucleosis saboda da babban hadarin da exanthema.

Nada wakili "Flemoklav-soljutab" tare da taka tsantsan a pathologies a cikin gastrointestinal fili, hanta gazawar (tsanani), koda gazawar (na kullum).

Yana rika dauka kafin cin abinci nan da nan su hana diarrheal manifestations na magani. Allunan ba laushi, ba chewed. Wanke saukar da shawarar cewa Yã isa zama adadin ruwa. Yana a yarda ta soke da miyagun ƙwayoyi a talatin milliliters na ruwa. Kafin shan dole ne ka ke motsa sosai.

A tsawon lokaci da warkewa Hakika kafa ta likita. Matsayin mai mulkin, magani ba ya šauki tsawon fiye da kwana goma sha huɗu.

Ga marasa lafiya wanda nauyi fiye da arba'in kilo wajabta sashi 0.5 g / 125 MG. Tafii da sau uku a rana.

A mafi kyau duka warkewa kashi na magani "Flemoklav-soljutab" yara daga watanni uku zuwa shekaru biyu ne 125 / 32.5 MG sau biyu a rana. Yara daga biyu zuwa shekaru 12, kara yawan receptions na har zuwa sau uku a rana.

Lokacin da samun magani iya samar da a ke so manifestations alerji, pseudomembranous colitis, candidiasis, ciwon mara, da sauransu. A yi, mai tsanani daga gefen effects dogara a kan sashi daga cikin miyagun ƙwayoyi. A lokuta da dama, ba a ke so illa da aka shafe bayan daidaitawa da sashi regimen.

Fiye wajabta kwayoyi "Flemoklav-soljutab" yara. Reviews iyaye a lokaci guda shubuha. Duk da haka, ya kamata a lura da cewa a general, da miyagun ƙwayoyi aka dauke su mai matuƙar tasiri da kuma sauri. A disadvantages da miyagun ƙwayoyi sau da yawa sun hada da wani babban alama na tasowa illa. Amma, kamar yadda muka gani a sama, da yawa m halayen warware bayan kashi sabawa.

Kafin shan wannan magani "Femoklav-soljutab" Ya kamata shawarci likita da kuma gano summary.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 ha.delachieve.com. Theme powered by WordPress.